Shehab, H. M., & Yasmin, H. (2024). A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine. Brac University.
Čikaški stil citiranja (17. izdanje)Shehab, Habibul Mohsin, i Hasina Yasmin. A Pharmacovigilance Study to Determine Risk of Mortality in Male and Female Patients with Alzheimer's Disease Using Rivastigmine. Brac University, 2024.
MLA način citiranja (8. izdanje)Shehab, Habibul Mohsin, i Hasina Yasmin. A Pharmacovigilance Study to Determine Risk of Mortality in Male and Female Patients with Alzheimer's Disease Using Rivastigmine. Brac University, 2024.
Upozorenje: Ovi citati možda nisu uvijek 100% točni.